NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst

Go back to NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst
(NASDAQ: NTHI) Delayed: 3.31 +0.01 (0.30%)
Previous Close $3.30    52 Week High $ 
Open $3.36    52 Week Low $ 
Day High $3.52    P/E N/A 
Day Low $3.25    EPS $ 
Volume 135,407